Cellectis S.A. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (27)

Latest Posts

About This Stock More About This Stock
Wells Fargo Sees Little Chance Of Higher Bid For Kite Pharma
Article By: The Fly
Monday, August 28, 2017 8:05 PM EST
Gilead and Kite Pharma have announced that the companies have entered into a definitive agreement pursuant to which the former will acquire the latter for $180 per share in cash.
In this article: GILD, JUNO, KITE, BLUE, CLLS
Read
BIO 2017 International #1: CAR-T Therapies On Solid Tumors
Article By: Rod Raynovich
Thursday, June 22, 2017 11:45 PM EST
CAR-T shows great promise against blood cancers but challenges remain for solid tumors. Bellicum Pharmaceuticals, Bluebird bio, Cellectis SA, Juno Therapeutics, Kite Pharma and Poseida Therapeutics are some of the major companies engaged in CAR-T.
In this article: JUNO, KITE, BLUE, CLLS, BLCM
Read
3 Biotech Stocks That Are Broker Favorites
Article By: Arpita Dutt
Tuesday, March 21, 2017 12:23 PM EST
Biotech stocks, which have been showing signs of recovery this year, slipped last week following the release of the Budget Blueprint for 2018.
In this article: BPMC, CLLS, MATN Also: BIIB, AMGN
Read
Best Stock Charts - Sunday, February 12
Video By: Robert Desmond
Sunday, February 12, 2017 9:24 PM EST
In this week’s commentary I discuss out Recent Trade which have been very profitable.
In this video: UVV, SWIR, AAPL, AMZN, DUST, FXY, GLD, NUGT, TZA, UUP, VIX, BLUE, CLLS, BRZU, ARNC
Watch
5 Great Biotech Stocks To Buy Now
Article By: Swarup Gupta
Tuesday, February 7, 2017 5:45 PM EST
Biotechs have recovered substantially from the losses they suffered up to early last year. Adding biotech stocks to your portfolio looks like a smart option at this point.
In this article: CELG, CLLS, EXEL, EXAS, SNSS Also: BMRN
Read

PARTNER HEADLINES

Latest Tweets for $CLLS

No tweets yet!